Therefore, we proposed that GOT2 overexpression might be coupled with activation of histidine degradation pathway and nucleotide synthesis pathways to decrease the cellular level of THF, thus sensitized breast cancer cells to MTX. The gene discussed is GOT2; the disease is breast cancer.